|Articles|July 7, 2015

Kenneth Freundlich on Support for Patients With Hereditary Cancers

Kenneth Freundlich, neuropsychologist, Morris Psychological Group, Parsippany, NJ, and FORCE volunteer, comments on supporting patients with hereditary cancers.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!

Related Content

CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma.

What Does Minimal Residual Disease Mean?

ByDr. Dickran Kazandjian

December 11th 2025

Preoperative Breast MRI Did Not Improve Outcomes in Early-Stage Breast Cancer

ByTim Cortese

December 11th 2025

Enhertu and Perjeta led to better quality-of-life and less side effects than standard-of-care among patients with HER2+ advanced or metastatic breast.

Enhertu/Perjeta Combo Enhances Quality of in HER2+ Advanced Breast Cancer

ByPaige Britt

December 11th 2025

Radiation Plus Keytruda Before Surgery Boosts Immune Response in Breast Cancer

ByRuss Conroy

December 11th 2025

Checkpoint Inhibitors May Impact Fertility in Early TNBC Treatment

BySilas Inman

December 11th 2025

Kenneth Freundlich on Support for Patients With Hereditary Cancers

Newsletter

Related Content

What Does Minimal Residual Disease Mean?

Preoperative Breast MRI Did Not Improve Outcomes in Early-Stage Breast Cancer

Enhertu/Perjeta Combo Enhances Quality of in HER2+ Advanced Breast Cancer

Radiation Plus Keytruda Before Surgery Boosts Immune Response in Breast Cancer

Checkpoint Inhibitors May Impact Fertility in Early TNBC Treatment

Trending on CURE

From Stage 4 to Survivor: Dan’s Pancreatic Cancer Journey

Giredestrant Improves Outcomes in ER+/HER2– Breast Cancer

Tukysa Combo Boosts Frontline Maintenance in Advanced HER2+ Breast Cancer

Suleika Jaouad Celebrates Blood Cancer Heroes With CURE and Blood Cancer United

Radiation Plus Keytruda Before Surgery Boosts Immune Response in Breast Cancer